Is Elanco Animal Stock a Good Investment?

Elanco Animal Investment Advice

  ELAN
To provide specific investment advice or recommendations on Elanco Animal Health stock, we recommend investors consider the following general factors when evaluating Elanco Animal Health. This will help you to make an informed decision on whether to include Elanco Animal in one of your diversified portfolios:
  • Examine Elanco Animal's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
  • Research Elanco Animal's leadership team and their track record. Good management can help Elanco Animal navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
  • Consider the overall health of the Pharmaceuticals space and any emerging trends that could impact Elanco Animal's business and its evolving consumer preferences.
  • Compare Elanco Animal's performance and market position to its competitors. Analyze how Elanco Animal is positioned in terms of product offerings, innovation, and market share.
  • Check if Elanco Animal pays a dividend and its dividend yield and payout ratio.
  • Review what financial analysts are saying about Elanco Animal's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in Elanco Animal Health stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if Elanco Animal Health is a good investment.
 
Sell
 
Buy
Hold
Our trade advice tool can cross-verify current analyst consensus on Elanco Animal Health and to analyze the company potential to grow in the current economic cycle. To make sure Elanco Animal is not overpriced, please confirm all Elanco Animal Health fundamentals, including its revenue, current ratio, and the relationship between the number of shares shorted and cash and equivalents . Given that Elanco Animal Health has a price to earning of 241.75 X, we urge you to verify Elanco Animal Health market performance and probability of bankruptcy to ensure the company can sustain itself in the current economic cycle given your prevailing risk tolerance and investing horizon.

Market Performance

InsignificantDetails

Volatility

Not too volatileDetails

Hype Condition

Low keyDetails

Current Valuation

OvervaluedDetails

Odds Of Distress

Below AverageDetails

Economic Sensitivity

Responds to the marketDetails

Investor Sentiment

InterestedDetails

Analyst Consensus

BuyDetails

Financial Strenth (F Score)

StrongDetails

Financial Leverage

Not RatedDetails

Reporting Quality (M-Score)

Unlikely ManipulatorDetails

Examine Elanco Animal Stock

Researching Elanco Animal's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). About 99.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 1.22. Some equities with similar Price to Book (P/B) outperform the market in the long run. Elanco Animal Health has Price/Earnings To Growth (PEG) ratio of 1.84. The entity recorded a loss per share of 2.55. The firm had not issued any dividends in recent years.
To determine if Elanco Animal is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Elanco Animal's research are outlined below:
The company reported the previous year's revenue of 4.42 B. Net Loss for the year was (1.23 B) with profit before overhead, payroll, taxes, and interest of 2.5 B.
Elanco Animal Health has a strong financial position based on the latest SEC filings
Over 99.0% of the company shares are held by institutions such as insurance companies
Latest headline from accesswire.com: Investors Are Invited To Join The Schall Law Firm In An Inquiry Into Elanco Animal Health Incorporated For Possible Securities Fraud

Elanco Animal Quarterly Liabilities And Stockholders Equity

13.76 Billion

Elanco Animal uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Elanco Animal Health. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Elanco Animal's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
20th of February 2024
Upcoming Quarterly Report
View
14th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
20th of February 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
31st of December 2022
Last Financial Announcement
View
Earnings surprises can significantly impact Elanco Animal's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate. Below are the table of largest EPS Surprises Elanco Animal's investors have experienced.
Reported
Fiscal Date
Estimated EPS
Reported EPS
Surprise
2021-11-05
2021-09-300.170.190.0211 
2024-02-26
2023-12-310.110.08-0.0327 
2021-02-24
2020-12-310.090.120.0333 
2020-07-30
2020-06-300.060.090.0350 
2022-11-08
2022-09-300.160.20.0425 
2022-02-24
2021-12-310.170.210.0423 
2019-11-06
2019-09-300.260.30.0415 
2018-11-06
2018-09-300.250.290.0416 

Elanco Animal Target Price Consensus

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Elanco target price is determined by taking all analyst projections and averaging them out. There is no one specific way to measure analysts' performance other than comparing it to past results via a very sophisticated attribution analysis. Elanco Animal's target price projections below should be used in combination with other traditional price prediction techniques such as stock price forecasting, investor sentiment analysis, technical analysis, earnings estimate, and various momentum models.
   14  Buy
Most Elanco analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to help potential investors understand Elanco stock's fair price compared to its market value. Analysts arrive at stock ratings after researching the public financial statements of Elanco Animal Health, talking to its executives and customers, or listening to those companies' conference calls.
Macroaxis Advice   Exposure   Valuation

Elanco Animal Target Price Projection

Elanco Animal's current and average target prices are 14.66 and 13.81, respectively. The current price of Elanco Animal is the price at which Elanco Animal Health is currently trading. On the other hand, Elanco Animal's target price is what analysts think the stock is worth or could sell for in the future. The more significant the discrepancy between the two prices, the more it stimulates investors to act.

Current Price

Elanco Animal Market Quote on 5th of October 2024

Low Price14.34Odds
High Price14.79Odds

14.66

Target Price

Analyst Consensus On Elanco Animal Target Price

Low Estimate12.57Odds
High Estimate15.33Odds

13.81

Historical Lowest Forecast  12.57 Target Price  13.81 Highest Forecast  15.33
Note that most analysts generally publish their price targets in research reports on specific companies, along with recommendations for the company's stock.Although price targets are often quoted in the financial news media, there could be a delay between the publication of the latest analyst outlook on Elanco Animal Health and the information provided on this page.

Elanco Animal Analyst Ratings

Elanco Animal's analyst stock recommendations are determined by taking an average estimate of all analysts we track and classifying them as Strong Buy, Buy, Hold, Strong Sell, or Sell. Ratings generally communicate what analysts sense about Elanco Animal stock, and they use a lot of effort and time to analyze it and arrive at a rating. That suggests that analyst recommendations are the outcome of an objective and thorough examination of Elanco Animal's financials, market performance, and future outlook by experienced professionals. Elanco Animal's historical ratings below, therefore, can serve as a valuable tool for investors.

Know Elanco Animal's Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Elanco Animal is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Elanco Animal Health backward and forwards among themselves. Elanco Animal's institutional investor refers to the entity that pools money to purchase Elanco Animal's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
Shapiro Capital Management Co Inc2024-06-30
9.6 M
Millennium Management Llc2024-06-30
9.4 M
Magnetar Financial Llc2024-06-30
8.3 M
Geode Capital Management, Llc2024-06-30
7.8 M
Manufacturers Life Insurance Co2024-06-30
M
Jpmorgan Chase & Co2024-06-30
5.7 M
Balyasny Asset Management Llc2024-06-30
5.4 M
Charles Schwab Investment Management Inc2024-06-30
4.7 M
Norges Bank2024-06-30
3.9 M
Dodge & Cox2024-06-30
83.6 M
Primecap Management Company2024-06-30
52.8 M
Note, although Elanco Animal's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Elanco Animal's market capitalization trends

The company currently falls under 'Mid-Cap' category with a current market capitalization of 7.25 B.

Market Cap

0.0

Elanco Animal's profitablity analysis

Last ReportedProjected for Next Year
Return On Tangible Assets(0.26)(0.24)
Return On Capital Employed 0.02  0.03 
Return On Assets(0.09)(0.08)
Return On Equity(0.20)(0.19)
The company has Profit Margin (PM) of (0.28) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of 0.1 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.1.
Determining Elanco Animal's profitability involves analyzing its financial statements and using various financial metrics to determine if Elanco Animal is a good buy. For example, gross profit margin measures Elanco Animal's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Elanco Animal's profitability and make more informed investment decisions.

Elanco Animal's Earnings Breakdown by Geography

Evaluate Elanco Animal's management efficiency

Elanco Animal Health has return on total asset (ROA) of 0.013 % which means that it generated a profit of $0.013 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (0.1879) %, meaning that it created substantial loss on money invested by shareholders. Elanco Animal's management efficiency ratios could be used to measure how well Elanco Animal manages its routine affairs as well as how well it operates its assets and liabilities. As of the 5th of October 2024, Return On Capital Employed is likely to grow to 0.03, though Return On Tangible Assets are likely to grow to (0.24). As of the 5th of October 2024, Asset Turnover is likely to grow to 0.33, while Total Assets are likely to drop about 13.6 B.
Last ReportedProjected for Next Year
Book Value Per Share 12.64  18.62 
Tangible Book Value Per Share(6.84)(6.49)
Enterprise Value Over EBITDA 13.50  23.56 
Price Book Value Ratio 1.18  1.76 
Enterprise Value Multiple 13.50  23.56 
Price Fair Value 1.18  1.76 
The analysis of Elanco Animal's management efficiency is an essential part of evaluating and assessing the financial and operational performance of the entity. It is also vital to analyze Elanco Animal's future growth prospects and the overall market conditions to determine the value and potential of its stock. The analysis involves studying a range of financial metrics such as revenue, earnings, profit margins, cash flow, debt, market share, and external factors such as economic trends, industry outlook, competition, and government regulations. The goal of Elanco Stock analysis is to determine whether it is undervalued, fairly valued, or overvalued and to make informed investment decisions.
Beta
1.402

Basic technical analysis of Elanco Stock

As of the 5th of October, Elanco Animal shows the Mean Deviation of 1.82, semi deviation of 2.22, and Downside Deviation of 2.34. Elanco Animal Health technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Elanco Animal's insider trading activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Elanco Animal insiders, such as employees or executives, is commonly permitted as long as it does not rely on Elanco Animal's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Elanco Animal insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.

Elanco Animal's Outstanding Corporate Bonds

Elanco Animal issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Elanco Animal Health uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Elanco bonds can be classified according to their maturity, which is the date when Elanco Animal Health has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.

Understand Elanco Animal's technical and predictive indicators

Using predictive indicators to make investment decisions involves analyzing Elanco Animal's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.

Consider Elanco Animal's intraday indicators

Elanco Animal intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Elanco Animal stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Elanco Animal Corporate Filings

F4
2nd of October 2024
The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities
ViewVerify
8K
8th of August 2024
Report filed with the SEC to announce major events that shareholders should know about
ViewVerify
13A
8th of July 2024
An amended filing to the original Schedule 13G
ViewVerify
28th of May 2024
Other Reports
ViewVerify
Elanco Animal time-series forecasting models is one of many Elanco Animal's stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Elanco Animal's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Elanco Stock media impact

Far too much social signal, news, headlines, and media speculation about Elanco Animal that are available to investors today. That information is available publicly through Elanco media outlets and privately through word of mouth or via Elanco internal channels. However, regardless of the origin, that massive amount of Elanco data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Elanco Animal news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Elanco Animal relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Elanco Animal's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Elanco Animal alpha.

Elanco Animal Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Elanco Animal can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Elanco Animal Health Historical Investor Sentiment

Investor biases related to Elanco Animal's public news can be used to forecast risks associated with an investment in Elanco. The trend in average sentiment can be used to explain how an investor holding Elanco can time the market purely based on public headlines and social activities around Elanco Animal Health. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Elanco Animal's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Elanco Animal and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Elanco Animal news discussions. The higher the estimate score, the more favorable the investor's outlook on Elanco Animal.

Elanco Animal Corporate Directors

Joshua SmileyIndependent DirectorProfile
Carl McMillianIndependent DirectorProfile
Denise ScotsKnightIndependent DirectorProfile
Kirk McDonaldIndependent DirectorProfile

Additional Information and Resources on Investing in Elanco Stock

When determining whether Elanco Animal Health offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Elanco Animal's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Elanco Animal Health Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Elanco Animal Health Stock:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Elanco Animal Health. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.
You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Elanco Animal. If investors know Elanco will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Elanco Animal listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.71)
Earnings Share
(2.55)
Revenue Per Share
9.107
Quarterly Revenue Growth
0.12
Return On Assets
0.013
The market value of Elanco Animal Health is measured differently than its book value, which is the value of Elanco that is recorded on the company's balance sheet. Investors also form their own opinion of Elanco Animal's value that differs from its market value or its book value, called intrinsic value, which is Elanco Animal's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Elanco Animal's market value can be influenced by many factors that don't directly affect Elanco Animal's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
In summary, please note that there is a difference between Elanco Animal's value and its price, as these two are different measures arrived at by various means. Investors typically determine if Elanco Animal is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Elanco Animal's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.